Association of Taurine with In-Hospital Mortality in Patients after Out-of-Hospital Cardiac Arrest: Results from the Prospective, Observational COMMUNICATE Study

• Published in: Journal of clinical medicine 2020-05, Vol.9 (5), p.1405
• Main Authors: Herzog, Naemi, Laager, Rahel, Thommen, Emanuel, Widmer, Madlaina, Vincent, Alessia M, Keller, Annalena, Becker, Christoph, Beck, Katharina, Perrig, Sebastian, Bernasconi, Luca, Neyer, Peter, Marsch, Stephan, Schuetz, Philipp, Sutter, Raoul, Tisljar, Kai, Hunziker, Sabina
• Format: Article
• Language: English
• Subjects: Age; Angina pectoris; Apoptosis; Cardiac arrest; Cardiovascular disease; Clinical medicine; Creatinine; Diabetes; Disability; Gender; Heart attacks; Heart failure; Hypertension; Intensive care; Kidneys; Mortality; Patients; Vital signs
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm9051405

Studies have suggested that taurine may have neuro- and cardio-protective functions, but there is little research looking at taurine levels in patients after out-of-hospital cardiac arrest (OHCA). Our aim was to evaluate the association of taurine with mortality and neurological deficits in a well-defined cohort of OHCA patients. We prospectively measured serum taurine concentration in OHCA patients upon admission to the intensive care unit (ICU) of the University Hospital Basel (Switzerland). We analyzed the association of taurine levels and in-hospital mortality (primary endpoint). We further evaluated neurological outcomes assessed by the cerebral performance category scale. We calculated logistic regression analyses and report odds ratios (OR) and 95% confidence intervals (CI). We calculated different predefined multivariable regression models including demographic variables, comorbidities, initial vital signs, initial blood markers and resuscitation measures. We assessed discrimination by means of area under the receiver operating curve (ROC). Of 240 included patients, 130 (54.2%) survived until hospital discharge and 110 (45.8%) had a favorable neurological outcome. Taurine levels were significantly associated with higher in-hospital mortality (adjusted OR 4.12 (95%CI 1.22 to 13.91), = 0.02). In addition, a significant association between taurine concentration and a poor neurological outcome was observed (adjusted OR of 3.71 (95%CI 1.13 to 12.25), = 0.03). Area under the curve (AUC) suggested only low discrimination for both endpoints (0.57 and 0.57, respectively). Admission taurine levels are associated with mortality and neurological outcomes in OHCA patients and may help in the risk assessment of this vulnerable population. Further studies are needed to assess whether therapeutic modulation of taurine may improve clinical outcomes after cardiac arrest.